Promoting and facilitating strategies to improve cardiovascular health worldwide
Promoting and facilitating strategies to improve cardiovascular health worldwide
Promoting and facilitating strategies to improve cardiovascular health worldwide
Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
ISCP ANNUAL GENERAL ASSEMBLY
The ISCP yearly General Assembly will take place in Amsterdam on Saturday 26th August at 13.00-14.30 CEST. If you are a Full Member and would like to attend, please let us know in advance as it will help us organise the logistics.
For those not able to attend in person, the session will be broadcasted live over Zoom. If you wish to attend online, please send an email to lourdesmarenco@icpcardio.org so you are added to the list and receive the login details to the meeting.
ESC 2023 @AMSTERDAM
The most expected event of the year in the cardiology world is taking place in Amsterdam this August and we are thrilled to confirm that we will be participating with a booth (A670) within the International Associations Row in the exhibition area. If you are planning on attending please come and say hi, would love to meet you!
ISCP will also participate in the scientific sessions. We will present a joint session ESC-ISCP titled “RNA-based therapy in cardiovascular disease: ready for prime time!” so look up for this session on the meeting’s programme and make sure not to miss it!
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
Our first five webinars produced in collaboration with our partners Radcliffe Cardiology are now available to view in the Webinars On Demand section:
1- Ferric Carboxymaltose: Ironing Out the Issues Around Heart Failure-Related Readmissions,
2- Inclisiran: A Jab Goes a Long Way,
3- Edoxaban: ENGAGEing in Individualisation of DOACs,
4- Valsartan Sacubitril: Has our PARADIGM shifted?,
5- Clopidogrel or Ticagrelor: Why, When, for Whom?, and
Details of future webinars will become available in Upcoming webinars very soon, including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Upcoming Events
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Hormone therapy use among menopausal women continues to decline, despite proven safety
Posted on September 13, 2024
CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical... more
Stopping abelacimab may not be necessary before invasive procedures
Posted on September 13, 2024
Patients with atrial fibrillation needing stroke prevention assigned to abelacimab had very low rates of bleeding during invasive procedures, according to new... more
Shared decision-making key for invasive vs. conservative MI strategy in elderly: SENIOR-RITA
Posted on September 13, 2024
For older adults with non-STEMI, routine coronary intervention was safe but did not lower risk for death from CV causes or nonfatal... more
Tirzepatide tied to lower odds for diabetic retinopathy, pancreatitis than GLP-1s
Posted on September 13, 2024
Tirzepatide is associated with similar odds for gastrointestinal adverse events and a lower likelihood for diabetic retinopathy and pancreatitis compared with GLP-1... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Alberto Lorenzatti
VP / President Elect
Affiliations/Memberships Founder and Past President of the Argentine Lipids Society (2003-2005); Current Chair of the Americas Federation from the International Atherosclerosis Society (IAS). Research Interests Atherosclerosis Lipid Metabolism Inflammation and CHD more
-
Georg Noll
Treasurer
Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more
-
Pablo Avanzas
Secretary
Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more
-
Sang Hong Baek
President
Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more
